Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.

MLA

Gagnon-Auger M, et al. “Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects with Type 2 Diabetes: A Pharmacokinetic and Pharmacodynamic Study.” Diabetes Care, vol. 33, no. 12, Dec. 2010, pp. 2502–07. EBSCOhost, https://doi.org/10.2337/dc10-1126.

APA

Gagnon-Auger M, du Souich P, Baillargeon JP, Martin E, Brassard P, Ménard J, Ardilouze JL, Gagnon-Auger, M., du Souich, P., Baillargeon, J.-P., Martin, E., Brassard, P., Ménard, J., & Ardilouze, J.-L. (2010). Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study. Diabetes Care, 33(12), 2502–2507. https://doi.org/10.2337/dc10-1126

Chicago

Gagnon-Auger M, du Souich P, Baillargeon JP, Martin E, Brassard P, Ménard J, Ardilouze JL, et al. 2010. “Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects with Type 2 Diabetes: A Pharmacokinetic and Pharmacodynamic Study.” Diabetes Care 33 (12): 2502–7. doi:10.2337/dc10-1126.